Vimarsana.com

Latest Breaking News On - Curie capital - Page 1 : vimarsana.com

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors

Precision oncology company Flindr Therapeutics announces €20 million Series A financing to advance first-in-class small molecule inhibitors
finanznachrichten.de - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from finanznachrichten.de Daily Mail and Mail on Sunday newspapers.

Netherlands
Velden
Limburg
Amsterdam
Noord-holland
Belgium
Cedric-van-nevel
Maarten-ligtenberg
Rudi-beyaert
Allard-kaptein
Innovatiefonds-noord-holland
Shobhit-dhawan

Sirius Medical Closes Series B €12M Funding

FinSMEs is the financial news site dedicated to covering venture capital, private equity, and merger and acquisition deals in real time!

Netherlands
United-states
Holland
Bram-schermers
Team-holmium
Sirius-medical
Holland-capital
Curie-capital
Western-europe

Sirius Medical Announces Major Funding Round To Further Accelerate Sales Growth And New Product Development

Sirius Pintuition® - Moving from Localization to Surgical Marker Navigation EINDHOVEN, Netherlands, March 28, 2023 /PRNewswire/ Sirius Medical, the leader in surgical marker navigation

United-states
Netherlands
Holland
Bram-schermers
Peter-stein
Jan-frens-van-giessel
Team-holmium
Netherlands-cancer-institute
Surgical-marker
Seriesb-round
Curie-capital
Sirius-medical

TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients

TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients Financing with equal contribution by an international investor syndicate comprising of Andera Partners, Fund+, Hadean Ventures, Inkef Capital and Sunstone Life Science Ventures .

Velden
Limburg
Netherlands
Utrecht
Olivier-litzka
Thrombocytopenia-purpura
Roger-franklin
Thijs-cohen-tervaert
Jacob-lange-moresco
Kristof-vercruysse
Coen-maas
Utrecht-health-seed-fund

TargED Biopharmaceuticals raises EUR 39 Million in Series A financing to bring groundbreaking thrombolytic treatment to patients

/PRNewswire/ TargED Biopharmaceuticals ("TargED"), a private biotechnology company focused on developing improved treatments for thrombotic diseases, today.

Norway
Germany
Munich
Bayern
Paris
France-general
France
Stockholm
Sweden
Utrecht
Netherlands
United-kingdom

vimarsana © 2020. All Rights Reserved.